Related Experiment Videos
Calcium channel diversity in the cardiovascular system
1Cardiology Division, University of Connecticut School of Medicine, Farmington, USA.
Journal of the American College of Cardiology
|August 1, 1996
Summary
Calcium (Ca2+) channels regulate cell signaling via intracellular release and plasma membrane influx. New drugs targeting T-type Ca2+ channels offer novel cardiovascular therapies.
Area of Science:
- Physiology
- Molecular Biology
- Pharmacology
Background:
- Calcium ions (Ca2+) act as crucial intracellular messengers.
- Ca2+ flux is regulated by intracellular release and plasma membrane channels.
- These channels are critical for various cellular functions, including muscle contraction and signal transduction.
Purpose of the Study:
- To review the distinct families of Ca2+ channel proteins.
- To highlight the roles of intracellular and plasma membrane Ca2+ channels.
- To discuss the therapeutic potential of novel T-type Ca2+ channel blockers.
Main Methods:
- Literature review of Ca2+ channel families and their functions.
- Discussion of known Ca2+ channel subtypes, including ryanodine receptors, InsP3-activated channels, L-type, and T-type channels.
- Analysis of current and emerging pharmacological agents targeting Ca2+ channels.
Main Results:
- Two main families of Ca2+ channels exist: intracellular release and plasma membrane channels.
- Specific subtypes like ryanodine receptors, InsP3-activated, L-type, and T-type channels have distinct physiological roles.
- L-type channels are key in cardiac excitation-contraction coupling and conduction, while T-type channels are implicated in smooth muscle and potentially cell growth.
Conclusions:
- Ca2+ channels are vital for physiological processes, with different subtypes having specialized functions.
- Existing cardiovascular drugs primarily target L-type Ca2+ channels.
- Selective T-type Ca2+ channel blockers represent a promising avenue for new cardiovascular treatments.